RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Mydecine Innovations Group Stock

Mydecine Innovations Group Debt 2024

Mydecine Innovations Group Debt

4.77 CAD

Ticker

MYCO.CN

ISIN

CA62849F2008

WKN

A3DKEJ

In 2024, Mydecine Innovations Group's total debt was 4.77 CAD, a 58.69% change from the 3.01 CAD total debt recorded in the previous year.

Mydecine Innovations Group Aktienanalyse

What does Mydecine Innovations Group do?

Mydecine Innovations Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Mydecine Innovations Group's Debt Structure

Mydecine Innovations Group's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Mydecine Innovations Group's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Mydecine Innovations Group’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Mydecine Innovations Group’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Mydecine Innovations Group stock

What is the debt of Mydecine Innovations Group this year?

Mydecine Innovations Group has a debt level of 4.77 CAD this year.

What was the debt of Mydecine Innovations Group compared to the previous year?

The debt of Mydecine Innovations Group has increased by 58.69% compared to the previous year increased.

What are the consequences of high debt for investors in Mydecine Innovations Group?

High debt can pose a risk for investors of Mydecine Innovations Group, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Mydecine Innovations Group?

Low debt means that Mydecine Innovations Group has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Mydecine Innovations Group affect the company?

An increase in debt of Mydecine Innovations Group can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Mydecine Innovations Group affect the company?

A reduction in debt of Mydecine Innovations Group can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Mydecine Innovations Group?

Some factors that can influence the debt of Mydecine Innovations Group include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Mydecine Innovations Group so important for investors?

The debts of Mydecine Innovations Group are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Mydecine Innovations Group take to change the debt?

To change the debt, Mydecine Innovations Group can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Mydecine Innovations Group pay?

Over the past 12 months, Mydecine Innovations Group paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Mydecine Innovations Group is expected to pay a dividend of 0 CAD.

What is the dividend yield of Mydecine Innovations Group?

The current dividend yield of Mydecine Innovations Group is .

When does Mydecine Innovations Group pay dividends?

Mydecine Innovations Group pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Mydecine Innovations Group?

Mydecine Innovations Group paid dividends every year for the past 0 years.

What is the dividend of Mydecine Innovations Group?

For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Mydecine Innovations Group located?

Mydecine Innovations Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Mydecine Innovations Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Mydecine Innovations Group from 11/18/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 11/18/2024.

When did Mydecine Innovations Group pay the last dividend?

The last dividend was paid out on 11/18/2024.

What was the dividend of Mydecine Innovations Group in the year 2023?

In the year 2023, Mydecine Innovations Group distributed 0 CAD as dividends.

In which currency does Mydecine Innovations Group pay out the dividend?

The dividends of Mydecine Innovations Group are distributed in CAD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Mydecine Innovations Group

Our stock analysis for Mydecine Innovations Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Mydecine Innovations Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.